510 related articles for article (PubMed ID: 33723397)
1. Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.
Sparber-Sauer M; Orbach D; Navid F; Hettmer S; Skapek S; Corradini N; Casanova M; Weiss A; Schwab M; Ferrari A
Br J Cancer; 2021 May; 124(10):1637-1646. PubMed ID: 33723397
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose.
Garg V; Gangadharaiah BB; Rastogi S; Upadhyay A; Barwad A; Dhamija E; Gamangatti S
Eur J Cancer; 2023 Jun; 186():142-150. PubMed ID: 37062211
[TBL] [Abstract][Full Text] [Related]
3. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
4. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients.
Papadopoulos S; Koulouris P; Royer-Chardon C; Tsoumakidou G; Dolcan A; Cherix S; Matter M; Omoumi P; Digklia A
Front Endocrinol (Lausanne); 2022; 13():794512. PubMed ID: 35399933
[TBL] [Abstract][Full Text] [Related]
6. Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.
Noujaim J; Gupta AA; Holloway CL; Saleh R; Srikanthan A; Lemieux C; Soroka HP; Tibout P; Turcotte R; Feng X; Abdul Razak AR; Costa P
Eur J Cancer; 2024 Jul; 205():114119. PubMed ID: 38759389
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of mammary desmoid-type fibromatosis: which benefit?
Scheer L; Lodi M; Molière S; Kurtz JE; Mathelin C
World J Surg Oncol; 2017 Apr; 15(1):86. PubMed ID: 28420393
[TBL] [Abstract][Full Text] [Related]
10. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Orbital Desmoid-type Fibromatosis With Sorafenib.
Downie EM; Amend CE; Miranda A; Burkat CN
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):e144-e147. PubMed ID: 35470290
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in desmoid-type fibromatosis in children and adults: A systematic review.
van Maren SA; van Noesel MM; Husson O; van der Graaf WTA
Pediatr Blood Cancer; 2022 Sep; 69(9):e29831. PubMed ID: 35714333
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor.
Robles J; Keskinyan VS; Thompson M; Davis JT; Mater DV
Pediatr Hematol Oncol; 2020 Aug; 37(5):445-449. PubMed ID: 32129687
[No Abstract] [Full Text] [Related]
16. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.
Di Gion P; Kanefendt F; Lindauer A; Scheffler M; Doroshyenko O; Fuhr U; Wolf J; Jaehde U
Clin Pharmacokinet; 2011 Sep; 50(9):551-603. PubMed ID: 21827214
[TBL] [Abstract][Full Text] [Related]
17. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option.
Sari M
J Cancer Res Ther; 2020; 16(4):900-902. PubMed ID: 32930137
[TBL] [Abstract][Full Text] [Related]
18. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
[TBL] [Abstract][Full Text] [Related]
19. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
[TBL] [Abstract][Full Text] [Related]
20. Therapy of desmoid tumors and fibromatosis using vinorelbine.
Weiss AJ; Horowitz S; Lackman RD
Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]